News
The contract, though sizable, is likely immaterial to CVS’ earnings. But it moves the company in a positive direction as it continues to struggle with recent challenges, an analyst said.
The California Public Employees’ Retirement System (CalPERS) has a new pharmacy benefits contract with CVS Caremark, the ...
Nuvem, a tech-enabled pharmacy service for community health providers, announced the addition of four seasoned executives to ...
GLP-1s drive a historic shift in traditional drug spending increases, outpacing specialty drug trends for the first time.
CVS Health’s Caremark business signed a new pharmacy benefits contract with the California Public Employees’ Retirement ...
Community members rally to save their CVS location on Pennsylvania Avenue SE, citing the importance of accessible health care ...
CVS Pharmacy Inc. and Vi-Jon LLC convinced a federal appeals court not to revive a proposed class action over their hand ...
5h
Zacks Investment Research on MSNCVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should KnowCVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...
22h
Upgraded Points on MSNEarn 25 Flying Blue Miles per $10 Spent at CVS for a Limited TimeThe largest pharmacy chain in the U.S. has a new partnership with one of our favorite frequent flyer programs. CVS Pharmacy has teamed up with Air France-KLM Flying Blue to allow members of the ...
Review CVS Health Corp (CVS:XNYS) stock and the current sustainability and ESG risk rating to help with your investing decisions.
There's little point in pouring hundreds of millions of dollars into creating a biosimilar if PBMs will refuse to cover it.
Review the current valuation for CVS Health Corp (CVS:XNYS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results